GlassScriptPhysician profile
Charles S Lambert
NPI 1881779890
$1,149.63
in general payments reported to CMS, 2019-2025
16 companies · $30.03 in 2025
The $30.03 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $230 · 2022: $364 · 2023: $277 · 2024: $248 · 2025: $30.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $536 · Education: $19.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $535.66 |
| Education | $19.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $271.35 | 2021-2024 | Lokelma, Farxiga |
| Amgen INC. | $165.35 | 2021-2023 | Parsabiv |
| Vifor Pharma, INC. | $137.29 | 2022-2024 | Veltassa |
| Bayer Healthcare Pharmaceuticals INC. | $110.30 | 2023-2024 | |
| Novo Nordisk INC | $70.62 | 2021 | |
| Travere Therapeutics, INC. | $62.79 | 2023-2025 | |
| Fresenius USA Marketing, INC. | $52.17 | 2022-2024 | |
| Amarin Pharma, INC. | $48.68 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $43.60 | 2023-2024 | Jynarque |
| Opko Pharmaceuticals, LLC | $36.87 | 2022-2024 | Rayaldee |
| Lilly USA, LLC | $30.75 | 2021 | |
| Mallinckrodt Hospital Products INC. | $29.23 | 2023 | Terlivaz |
| Aurinia Pharma U.S., INC. | $29.13 | 2024 | Lupkynis |
| Abbvie INC. | $24.60 | 2021 | |
| Akebia Therapeutics INC | $20.45 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, INC. | $16.45 | 2023 | Jynarque |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Lambert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.